-Adrenoceptor signaling in regenerating skeletal muscle after -agonist administration

Beitzel F, Sillence MN, Lynch GS. -Adrenoceptor signaling in regenerating skeletal muscle after -agonist administration. Am J Physiol Endocrinol Metab 293: E932–E940, 2007. First published July 10, 2007; doi:10.1152/ajpendo.00175.2007.—Stimulating the -adrenoceptor ( -AR) signaling pathway can enhance the functional repair of skeletal muscle after injury, but long-term use of -AR agonists causes -AR downregulation, which may limit their therapeutic effectiveness. The aim was to examine -AR signaling during early regeneration in rat fast-twitch [extensor digitorum longus (EDL)] and slow-twitch (soleus) muscles after bupivacaine injury and test the hypothesis that, during regeneration, -agonist administration does not cause -AR desensitization. Rats received either the -AR agonist fenoterol (1.4 mg kg 1 day 1 ip) or saline for 7 days postinjury. Fenoterol reduced -AR density in regenerating soleus muscles by 42%. Regenerating EDL muscles showed a threefold increase in -AR density, and, again, these values were 43% lower with fenoterol treatment. An amplified adenylate cyclase (AC) response to isoproterenol was observed in cell membrane fragments from EDL and soleus muscles 7 days postinjury. Fenoterol attenuated this increase in regenerating EDL muscles but not soleus muscles. -AR signaling mechanisms were assessed using AC stimulants (NaF, forskolin, and Mn ). Although -agonist treatment reduces -AR density in regenerating muscles, these muscles can produce large cAMP responses relative to healthy (uninjured) muscles. Desensitization of -AR signaling in regenerating muscles is prevented by altered rates of -AR synthesis and/or degradation, changes in G protein populations and coupling efficiency, and altered AC activity. These mechanisms have important therapeutic implications for modulating -AR signaling to enhance muscle repair after injury.